ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $47,000 | -13.0% | 1,148 | +1.2% | 0.01% | -25.0% |
Q2 2020 | $54,000 | +12.5% | 1,134 | 0.0% | 0.01% | -20.0% |
Q1 2020 | $48,000 | -2.0% | 1,134 | 0.0% | 0.01% | +11.1% |
Q4 2019 | $49,000 | +22.5% | 1,134 | 0.0% | 0.01% | +12.5% |
Q3 2019 | $40,000 | +33.3% | 1,134 | 0.0% | 0.01% | +33.3% |
Q2 2019 | $30,000 | -86.2% | 1,134 | -86.1% | 0.01% | -86.7% |
Q1 2019 | $218,000 | +66.4% | 8,134 | 0.0% | 0.04% | +40.6% |
Q4 2018 | $131,000 | -43.3% | 8,134 | -26.9% | 0.03% | -25.6% |
Q3 2018 | $231,000 | +29.1% | 11,134 | -5.5% | 0.04% | +19.4% |
Q2 2018 | $179,000 | -31.2% | 11,784 | +71.2% | 0.04% | -57.1% |
Q3 2017 | $260,000 | +28.7% | 6,884 | +10.4% | 0.08% | +9.1% |
Q1 2017 | $202,000 | – | 6,234 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |